Search Results - "Pan, Youli"

A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer by Pan, Youli, Zheng, Mingwu, Zhong, Lei, Yang, Jiao, Zhou, Shu, Qin, Ya, Xiang, Rong, Chen, Yuzong, Yang, Sheng-Yong

“…The clinical prognosis of pancreatic cancer remains rather disappointing despite tremendous efforts in exploring medical treatments in the past two decades…”
Get full text

SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In Vivo by Zhang, Shuang, Cao, Zhixing, Tian, Hongwei, Shen, Guobo, Ma, Yongping, Xie, Huanzhang, Liu, Yalin, Zhao, Chengjian, Deng, Senyi, Yang, Yang, Zheng, Renlin, Li, Weiwei, Zhang, Na, Liu, Shengyong, Wang, Wei, Dai, Lixia, Shi, Shuai, Cheng, Lin, Pan, Youli, Feng, Shan, Zhao, Xia, Deng, Hongxin, Yang, Shengyong, Wei, Yuquan

“…VEGF receptor 2 (VEGFR2) inhibitors, as efficient antiangiogenesis agents, have been applied in the cancer treatment. However, currently most of these…”
Get full text

YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models by Xia, Yong, Song, Xuejiao, Li, Deliang, Ye, Tinghong, Xu, Youzhi, Lin, Hongjun, Meng, Nana, Li, Guobo, Deng, Senyi, Zhang, Shuang, Liu, Li, Zhu, Yongxia, Zeng, Jun, Lei, Qian, Pan, Youli, Wei, Yuquan, Zhao, Yinglan, Yu, Luoting

“…Antagonizing vascular endothelial growth factor receptor 2 (VEGFR2) to block angiogenesis has been applied toward cancer therapy for its role in promoting…”
Get full text

SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants, ErbB2, ErbB4, and VEGFR2, displays potent antitumor activity both in vitro and in vivo by Pan, Youli, Xu, Yong, Feng, Shan, Luo, Shidong, Zheng, Renlin, Yang, Jiao, Wang, Lijiao, Zhong, Lei, Yang, Han-Yu, Wang, Bing-Lin, Yu, Yang, Liu, Jingjing, Cao, Zhixing, Wang, Xiaoyan, Ji, Pan, Wang, Zerong, Chen, Xin, Zhang, Shuang, Wei, Yu-Quan, Yang, Sheng-Yong

“…Anti-epidermal growth factor receptor (EGFR) treatment has been successfully applied in clinical cancer therapy. However, the clinical efficacy of…”
Get full text